RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+9.4%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$958M
AUM Growth
+$958M
(+0.36%)
Cap. Flow
+$840K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
27.27%
Holding
97
New
7
Increased
32
Reduced
18
Closed
4
Top Buys
| 1 |
HCA Healthcare
HCA
|
$11.3M |
| 2 |
Medtronic
MDT
|
$8.55M |
| 3 |
Bio-Techne
TECH
|
$7.46M |
| 4 |
Tenet Healthcare
THC
|
$6.18M |
| 5 |
Cencora
COR
|
$6.13M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$21.7M |
| 2 |
Intuitive Surgical
ISRG
|
$11.9M |
| 3 |
UnitedHealth
UNH
|
$8.91M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$8.1M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.88M |
Sector Composition
| 1 | Healthcare | 99.1% |
| 2 | Industrials | 0.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Natera
NTRA
$23B
| $6.63M | 0.69% |
165,000
+85,000
| +106% | +$3.41M |
|
|
ITCI
52
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.62M | 0.69% |
125,000
| – | – |
|
|
KRTX
53
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $5.9M | 0.62% |
30,000
+10,000
| +50% | +$1.97M |
|
54
West Pharmaceutical
WST
$17.9B
| $5.88M | 0.61% |
25,000
+8,000
| +47% | +$1.88M |
|
55
Esperion Therapeutics
ESPR
$490M
| $5.61M | 0.59% |
900,000
| – | – |
|
56
Veeva Systems
VEEV
$44.4B
| $5.57M | 0.58% |
34,500
| – | – |
|
57
Iovance Biotherapeutics
IOVA
$800M
| $5.52M | 0.58% |
864,378
+354,378
| +69% | +$2.26M |
|
58
Envista
NVST
$3.37B
| $5.52M | 0.58% |
163,800
+20,000
| +14% | +$673K |
|
59
Exact Sciences
EXAS
$9.33B
| $5.45M | 0.57% |
110,000
+34,000
| +45% | +$1.68M |
|
|
OSH
60
DELISTED
Oak Street Health, Inc.
OSH
| $5.38M | 0.56% |
+250,000
| New | +$5.38M |
|
|
SGEN
61
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.27M | 0.55% |
41,000
| – | – |
|
|
OLK
62
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $4.93M | 0.51% |
194,390
| – | – |
|
63
Phreesia
PHR
$1.81B
| $4.85M | 0.51% |
150,000
+25,000
| +20% | +$809K |
|
|
VRAY
64
DELISTED
ViewRay, Inc.
VRAY
| $4.48M | 0.47% |
1,000,000
| – | – |
|
|
RCM
65
DELISTED
R1 RCM Inc. Common Stock
RCM
| $4.14M | 0.43% |
378,000
| – | – |
|
66
Agilon Health
AGL
$497M
| $4.12M | 0.43% |
255,000
| – | – |
|
67
IQVIA
IQV
$31.4B
| $4.1M | 0.43% |
+20,000
| New | +$4.1M |
|
68
Alkermes
ALKS
$4.95B
| $3.92M | 0.41% |
150,000
| – | – |
|
69
Alignment Healthcare
ALHC
$3.23B
| $3.82M | 0.4% |
325,000
+50,050
| +18% | +$589K |
|
70
Glaukos
GKOS
$5.42B
| $3.71M | 0.39% |
85,000
| – | – |
|
71
MeiraGTx Holdings
MGTX
$590M
| $3.62M | 0.38% |
555,030
| – | – |
|
72
Teladoc Health
TDOC
$1.37B
| $3.07M | 0.32% |
130,000
| – | – |
|
73
Relay Therapeutics
RLAY
$709M
| $2.99M | 0.31% |
+200,000
| New | +$2.99M |
|
74
Arvinas
ARVN
$580M
| $2.91M | 0.3% |
85,000
+35,000
| +70% | +$1.2M |
|
75
10x Genomics
TXG
$1.66B
| $2.73M | 0.29% |
75,000
| – | – |
|